Blood Collection Tubes Market Size, Share Global Analysis Report, 2026-2034

Industry Insights

[235+ Pages Report] According to Facts & Factors, the global Blood Collection Tubes market size was estimated at USD 2.45 billion in 2025 and is expected to reach USD 4.35 billion by the end of 2034. The Blood Collection Tubes industry is anticipated to grow by a CAGR of 6.6% between 2026 and 2034. The Blood Collection Tubes Market is driven by the steady rise in diagnostic testing volumes, expanding preventive healthcare screening programs, and increasing prevalence of chronic and infectious diseases requiring regular blood monitoring.

Market Overview

The blood collection tubes market encompasses specialized evacuated (vacuum) or non-evacuated plastic or glass tubes used for the safe, hygienic, and standardized collection of venous blood samples for diagnostic, monitoring, and research purposes. These tubes contain various additives (clot activators, anticoagulants such as EDTA, heparin, citrate, fluoride, or gel separators) tailored to specific downstream laboratory tests, including hematology, biochemistry, serology, coagulation, molecular diagnostics, blood banking, and therapeutic drug monitoring. The market serves hospitals, diagnostic laboratories, blood banks, clinics, physician offices, and home-collection services, with ongoing emphasis on improving sample integrity, reducing hemolysis/pre-analytical errors, enhancing traceability through barcoding/RFID, adopting safer plastic materials, and complying with international standards (ISO 6710, CLSI, WHO guidelines).

Key Insights

• As per the analysis shared by our research analyst, the global Blood Collection Tubes market is estimated to grow annually at a CAGR of around 6.6% over the forecast period (2026-2034).
• In terms of revenue, the global Blood Collection Tubes market size was valued at around USD 2.45 billion in 2025 and is projected to reach USD 4.35 billion by 2034.
• The global Blood Collection Tubes market is projected to grow at a significant rate due to rising diagnostic testing volumes, preventive health check-ups, and increasing chronic disease burden.
• Based on the Type, the Serum Separating Tubes segment accounted for the largest market share of around 32% in 2025, due to their widespread use in routine biochemistry and serology testing.
• Based on the Material, the Plastic segment accounted for the largest market share of around 78% in 2025, due to superior safety, lower breakage risk, lighter weight, and cost-effectiveness compared to glass.
• Based on the Application, the Routine Blood Testing segment accounted for the largest market share of around 48% in 2025, due to the sheer volume of general health check-ups and outpatient diagnostics.
• Based on region, Asia Pacific was the leading revenue generator in 2025, with approximately 42% share, due to a massive population, rapidly expanding diagnostic laboratory networks, and increasing preventive screening programs in India and China.

Growth Drivers

• Rising Volume of Diagnostic Testing Globally

The steady increase in routine health check-ups, preventive screening programs (diabetes, lipid profile, thyroid, cancer markers), infectious disease surveillance (HIV, hepatitis, dengue, COVID serology), and chronic disease monitoring (CKD, CVD, oncology) continues to drive exponential growth in blood draw volumes, especially in middle-income countries where diagnostic access is expanding rapidly.

Aging populations in both developed and emerging markets, combined with the rising prevalence of lifestyle diseases (diabetes, hypertension, dyslipidemia) and cancer, are increasing demand for frequent blood monitoring, directly translating into higher consumption of evacuated tubes across all tube types (SST, EDTA, fluoride, citrate, heparin).

Restraints

• Price Pressure from Government Tenders & Pooled Procurement

In many countries (especially emerging markets), blood collection tubes are procured through centralized government tenders, rate contracts, or pooled buying by large diagnostic chains, creating intense downward pressure on average selling prices and squeezing manufacturer margins.

Competition from low-cost local and Chinese manufacturers offering non-branded or semi-branded tubes continues to erode the share of multinational brands in price-sensitive segments, particularly for basic EDTA and serum tubes.

Opportunities

• Transition to Plastic & Safety-Engineered Tubes

Regulatory push and hospital preference for plastic over glass (due to breakage risk and sharps injury reduction) combined with growing adoption of safety-engineered blood collection sets (needle holders with shields, winged sets) create a multi-year upgrade cycle and premium pricing opportunity in both developed and middle-income markets.

Rising demand for specialized tubes, including cell-free DNA (cfDNA) tubes for liquid biopsy, RNA stabilization tubes, pediatric microtainers, and rapid serum tubes, is opening higher-margin niche segments in oncology, prenatal screening, and point-of-care diagnostics.

Challenges

• Maintaining Supply-Chain Stability for Key Raw Materials

Evacuated tube production depends on a consistent supply of medical-grade PET/PETG resin, butyl rubber stoppers, double-sided needles, and clot activators/gel. Any disruption (resin shortages, freight cost spikes, plant shutdowns) can lead to regional allocation challenges and price increases.

Pre-analytical variability (improper mixing, delayed centrifugation, hemolysis) continues to cause significant lab rejection rates, putting pressure on manufacturers to improve tube design and educate end-users on best practices.

Report Scope

Market Segmentation

The Blood Collection Tubes market is segmented by Type, Material, Application, and region.

Based on Type Segment, the Blood Collection Tubes market is divided into Serum Separating Tubes, EDTA Tubes, Plasma Separating Tubes, Heparin Tubes, Glucose Tubes, and others. The most dominant segment is Serum Separating Tubes (SST), which holds the largest share due to their widespread use in routine biochemistry, serology, and hormone testing the highest-volume test categories in most laboratories; it drives the market by generating the largest unit consumption and benefiting from frequent health check-up programs. The second most dominant is EDTA Tubes, essential for hematology and complete blood count (CBC) the single most frequently ordered test panel worldwide; this segment contributes significantly to steady demand across all care settings.

Based on Material Segment, the Blood Collection Tubes market is divided into Plastic, Glass, and others. The most dominant segment is Plastic (PET/PETG), commanding the highest share because of superior safety (break-resistant), lighter weight for shipping, lower hemolysis risk, and global manufacturing scale; it propels market expansion by being the default choice in new installations and replacement cycles. The second most dominant is Glass, still used in select high-end coagulation and trace-element testing; this segment maintains relevance in specialized laboratories despite declining overall share.

Based on Application Segment, the Blood Collection Tubes market is divided into Routine Blood Testing, Molecular Diagnostics, Blood Banking, Coagulation Testing, and others. The most dominant segment is Routine Blood Testing, with the largest share owing to the massive daily volume of general biochemistry, hematology, and serology panels performed in outpatient and hospital settings; it fuels market growth by creating consistent, high-volume demand across all geographies. The second most dominant is Blood Banking, driven by transfusion medicine requirements; this segment supports market development through specialized multi-bag systems and traceability features.

Recent Developments

• In early 2025, BD (Becton Dickinson) expanded production of its Vacutainer® SST II Advance tubes with improved gel barrier technology in India and Mexico to serve growing Asian and Latin American demand.
• In late 2024, Greiner Bio-One received expanded FDA clearance and CE mark for its new VACUETTE® CAT Serum Fast Separator Tube designed for rapid clotting and shorter centrifugation time.
• In mid-2024, FL Medical (Italy) launched a new line of DEHP-free PET tubes with safety-engineered needle holders targeting European and Middle Eastern hospitals.

Regional Analysis

• Asia Pacific to dominate the global market

Asia Pacific dominates the global Blood Collection Tubes market, propelled by the world’s largest population, highest number of annual diagnostic tests, fastest-growing private laboratory chains, expanding hospital bed capacity, and increasing preventive health check-up programs. India and China together account for the majority of global consumption. India emerges as the single most dominant country, with the largest number of private diagnostic laboratories, massive corporate hospital chains (Apollo, Fortis, Manipal), and government-led preventive screening initiatives all supported by domestic manufacturers (Hindustan Syringes, Poly Medicure, Romsons) and multinational capacity expansions in the country.

North America holds a high-value position with near-universal use of safety-engineered tubes and advanced additives. The United States dominates as the key country, with very high per-test sophistication, strong preference for branded premium tubes, and large reference laboratory networks (Quest, Labcorp) driving innovation and quality standards.

Europe maintains a mature, premium position with strong adoption of non-PVC and safety-engineered tubes. Germany and France are the leading countries, with Germany benefiting from its domestic manufacturing strength (Sarstedt, Greiner) and France from centralized public procurement.

Latin America is growing steadily, driven by private lab expansion and hospital modernization. Brazil dominates as the primary country, with large private laboratory networks and increasing use of component blood collection tubes.

The Middle East & Africa region is expanding in urban centers and private healthcare. The United Arab Emirates and Saudi Arabia are the leading countries, with high-end hospitals adopting premium international brands to meet JCI accreditation standards.

Competitive Analysis

The global Blood Collection Tubes market is dominated by players:

• Becton Dickinson and Company (BD)
• Greiner Bio-One International GmbH
• Terumo Corporation
• Sekisui Medical Co., Ltd.
• FL Medical s.r.l.
• Sarstedt AG & Co. KG
• Improve Medical Instruments Co., Ltd.
• CML Biotech Pvt. Ltd.
• Hindustan Syringes & Medical Devices Ltd.
• GPC Medical Ltd.

The global Blood Collection Tubes market is segmented as follows:

By Type

• Serum Separating Tubes
• EDTA Tubes
• Plasma Separating Tubes
• Heparin Tubes
• Glucose Tubes
• Others

By Material

• Plastic
• Glass
• Others

By Application

• Routine Blood Testing
• Molecular Diagnostics
• Blood Banking
• Coagulation Testing
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America